60 Degrees Pharmaceuticals Inc. (SXTP)
NASDAQ · Healthcare
60 Degrees Pharmaceuticals Inc. Operating Income 2020–2025
60 Degrees Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- 60 Degrees Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -2.1 M, a 9.63% increase year-over-year.
- 60 Degrees Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -7.9 M.
- 60 Degrees Pharmaceuticals Inc. annual operating income for 2025 was -7.8 M, a 20.14% decrease from 2024.
- 60 Degrees Pharmaceuticals Inc. annual operating income for 2024 was -9.7 M, a 88.47% increase from 2023.
- 60 Degrees Pharmaceuticals Inc. annual operating income for 2023 was -5.2 M, a 194.47% increase from 2022.
- 60 Degrees Pharmaceuticals Inc. annual operating income for 2022 was -1.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
60 Degrees Pharmaceuticals Inc. Operating Income — FAQ
60 Degrees Pharmaceuticals Inc. (SXTP) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is 60 Degrees Pharmaceuticals Inc.'s operating income?
60 Degrees Pharmaceuticals Inc. (SXTP) reported operating income of -$8M for fiscal 2025.
Where can I see SXTP's operating income history?
The chart and table above show 60 Degrees Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.